Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

NSE/ARTEMISMED stock hub

NSE/ARTEMISMED has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/ARTEMISMEDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

42.1B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/ARTEMISMED

In the news

Latest news · NSE/ARTEMISMED

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E31.3

P25 24.9P50 32.4P75 45.7

Trailing P/E40.5

P25 24.8P50 35.9P75 56.9

ROE11.6

P25 6.3P50 13.6P75 18.1

ROIC13.9

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/ARTEMISMED market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

229

Groups with data

Currency

INR

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	2,077
Employees Change	86%
Employees Change Percent	4.32
Enterprise value	INR 42.7B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	INE025R01021
Last refreshed	2026-05-10
Market cap	INR 42.1B
Price	INR 266
Price currency	INR
Rev Per Employee	5,349,405.87x
Sector	Healthcare
Sic	8062
Symbol	nse/ARTEMISMED
Website	https://www.artemishospitals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.46%
EV Earnings	41.18x
EV/EBIT	25.11x
EV/EBITDA	19.57x
EV/FCF	158.04x
EV/Sales	3.84x
FCF yield	0.64%
Forward P/E	31.26x
P/B ratio	4.47x
P/E ratio	40.5x
P/S ratio	3.79x
PE Ratio3 Y	45.87x
PE Ratio5 Y	35.39x
PEG ratio	1.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.3%
EBITDA Margin	19.62%
FCF margin	2.43%
Gross margin	26.41%
Gross Profit	INR 2.9B
Gross Profit Growth	48.4%
Gross Profit Growth Q	164.59%
Gross Profit Growth3 Y	28.54%
Gross Profit Growth5 Y	38.72%
Net Income	INR 1B
Net Income Growth	25.41%
Net Income Growth Q	28.3%
Net Income Growth Quarters	11%
Net Income Growth Years	4%
Net Income Growth3 Y	38.98%
Net Income Growth5 Y	74.06%
Pretax Margin	12.53%
Profit Margin	9.33%
Profit Per Employee	INR 498,889
Profitable Years	11
ROA	7.62
Roa5y	5.81
ROCE	13.95
ROE	11.63
Roe5y	10.95
ROIC	13.95
Roic5y	10.42

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	13.16%
Cagr3y	51.62%
Cagr5y	64.67%
EPS Growth	23.54
EPS Growth Q	28.68
EPS Growth Quarters	11
EPS Growth Years	4
EPS Growth3 Y	32.97
EPS Growth5 Y	68.02
FCF Growth	-48.54%
OCF Growth	-9.39%
OCF Growth3 Y	1.24%
OCF Growth5 Y	37.08%
Revenue Growth	18.59x
Revenue Growth Q	17.33x
Revenue Growth Quarters	19x
Revenue Growth Years	4x
Revenue Growth3 Y	14.64x
Revenue Growth5 Y	22.16x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 0.8
Assets	INR 14.3B
Cash	INR 2.1B
Current Assets	INR 3.7B
Current Liabilities	INR 2.1B
Debt	INR 2.6B
Debt EBITDA	INR 1.2
Debt Equity	INR 0.28
Debt FCF	INR 9.69
Equity	INR 9.4B
Interest Coverage	6.14
Liabilities	INR 4.9B
Long Term Assets	INR 10.6B
Long Term Liabilities	INR 2.8B
Net Cash	INR -554.2M
Net Cash By Market Cap	INR -1.32
Net Debt EBITDA	INR 0.25
Net Debt Equity	INR 0.06
Net Debt FCF	INR 2.05
Tangible Book Value	INR 8.8B
Tangible Book Value Per Share	INR 55.75
WACC	5.84

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.74
Inventory Turnover	69.9
Net Working Capital	INR -94.1M
Quick ratio	1.55
Working Capital	INR 1.6B
Working Capital Turnover	INR 4.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.45%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 0.45
Dividend Years	3
Dividend Yield	0.17%
Ex Div Date	2025-07-11
Last Dividend	INR 0.45
Payout Frequency	Annual
Payout Ratio	5.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	13.15%
200-day SMA	245.2
3Y total return	248.67%
50-day SMA	232.8
50-day SMA vs 200-day SMA	50under200
5Y total return	1,110.22%
All Time High	350
All Time High Change	-24%
All Time High Date	2024-12-19
All Time Low	10.67
All Time Low Change	2,392.97%
All Time Low Date	2020-03-24
ATR	9.02
Beta	0.27
Beta1y	0.54
Beta2y	0.39
Ch YTD	-1.86
High	271
High52	297.5
High52 Date	2025-11-18
High52ch	-10.59%
Low	258.6
Low52	203.4
Low52 Date	2026-03-30
Low52ch	30.81%
Ma50ch	14.28%
Price vs 200-day SMA	8.49%
RSI	73.63
RSI Monthly	55.77
RSI Weekly	57.99
Sharpe ratio	0.14x
Sortino ratio	0.38
Total Return	-1.28%
Tr YTD	-1.86
Tr1m	18.41%
Tr1w	6.49%
Tr3m	22.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 1.7B
Operating Income Growth	57.21
Operating Income Growth Q	77.87
Operating Income Growth3 Y	38.54
Operating Income Growth5 Y	64.08
Operating margin	15.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	32,294,630%
Net Borrowing	-166,079,000
Shares Insiders	3.08%
Shares Institutions	1.81%
Shares Out	158,306,247
Shares Qo Q	-0.27%
Shares Yo Y	1.45%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR 270M
Average Volume	216,945.65x
Bv Per Share	59.16
CAPEX	INR -1B
Ch1m	18.41
Ch1w	6.49
Ch1y	12.95
Ch3m	22.4
Ch3y	245.9
Ch5y	1,100.6
Ch6m	8.6
Change	0.45%
Change From Open	0.85
Close	264.8
Days Gap	-0.4
Depreciation Amortization	480,664,000
Dollar Volume	53,875,374
Earnings Date	2026-05-08
EBIT	INR 1.7B
EBITDA	INR 2.2B
EPS	INR 6.56
F Score	6
FCF	INR 270M
FCF EV Yield	0.63x
FCF Per Share	INR 1.71
Financing CF	-501,013,000
Fiscal Year End	March
Founded	2,004
Goodwill	416,207,000
Graham Number	93.44292
Graham Upside	-64.87
Income Tax	INR 354.6M
Investing CF	-900,296,000
Is Primary Listing	1
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Date	2021-09-23
Last Split Type	Forward
Lynch Fair Value	INR 164
Lynch Upside	-38.35
Ma150	247.3
Ma150ch	7.55%
Ma20	239.9
Ma20ch	10.86%
Net CF	-81,835,000
Next Earnings Date	2026-08-05
Open	263.8
P FCF Ratio	155.8
P OCF Ratio	31.87
Payment Date	2025-08-29
Position In Range	59.68
Ppne	7,790,451,000
Price Date	2026-05-08
Price EBITDA	INR 19.29
Ptbv Ratio	4.77
Relative Volume	0.92x
Revenue	11,110,716,000x
Tax By Revenue	3.19x
Tax Rate	25.48%
Tr6m	8.6%
Volume	202,539

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/ARTEMISMED dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.2%

$0.45 annual per share

Payout ratio

+5.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

-1.3%

Next ex-dividend date: 2025-07-11

Performance

NSE/ARTEMISMED stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/ARTEMISMED?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.8%

Share of float held by funds and institutions

Insider ownership

+3.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.4%

Negative means the company is buying back shares.

Technical

NSE/ARTEMISMED momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

73.6

Above 70: short-term overbought

Price vs 200-day MA

+8.5%

50/200-day relationship not available

Beta (5Y)

0.27

Less volatile than the market

Sharpe ratio

0.14

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/ARTEMISMED

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/ARTEMISMED stock rating?

nse/ARTEMISMED is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/ARTEMISMED analysis?

The full report lives at /stocks/nse/ARTEMISMED/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/ARTEMISMED?

The latest report frames nse/ARTEMISMED around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/ARTEMISMED page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.